The androgen receptor (AR) is a steroid hormone receptor widely detected in breast cancer.
Evidence suggests that the AR might be a tumor suppressor in estrogen receptor alpha …

Background Androgen receptor (AR) is considered a marker of better prognosis in hormone
receptor positive breast cancers (BC), however, its role in triple negative breast cancer …

In the era of personalized oncology biomarkers that identify subgroups of specific cancers
and help predict response to specific therapies are critical tools for prognosis determination …

Aromatase inhibitors (Ais) are used as adjuvant endocrine therapy for oestrogen receptor‐
positive (ER+ ve) post‐menopausal breast cancer patients. Ais, by inhibiting the enzyme …

Breast cancer is commonly thought of as a “women's disease”. However, men are
increasingly diagnosed with the disease, and their mortality rates are disparately higher than …

Background The glucocorticoid receptor (GR) is frequently expressed in breast cancer (BC),
and its prognostic implications are contingent on estrogen receptor (ER) status. To address …

Background Breast cancer is the most commonly diagnosed cancer among women
worldwide, and it is associated with significant number of metabolic and reproductive risk …

(1) Background: Hormone receptor positive breast cancer is a subtype of breast cancer with
relatively good prognosis, but luminal B (HER–2 negative) breast cancer has a higher risk of …

ABSTRACT The 43rd Annual Conference of the Indian Association of Cancer Research
(IACR) was held between 19th and 22nd January 2024 at the Indian Institute of Education …

We aimed to analyze the frequency of breast cancer relapses and their relationship with
molecular and biological tumor characteristics. We studied 6,136 breast cancer patients …